secwatch.observer — SEC 8-K summary
======================================

Issuer:     SELLAS Life Sciences Group, Inc. (SLS)
CIK:        0001390478
Form:       8-K
Filed at:   2023-03-01T23:59:59+00:00
Accession:  0001104659-23-027009
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

SELLAS closes $18.5M offering; reprices 3.4M warrants to $3.62
--------------------------------------------------------------

- Closed underwritten offering of 7,220,217 shares and warrants for net proceeds of ~$18.5M.
- Amended 3,438,851 warrants issued April 2022, reducing exercise price from $5.40 to $3.62.
- New exercise price equals average closing price over five trading days before offering pricing.
- Offering and warrant amendments executed on February 28, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1390478/000110465923027009/0001104659-23-027009-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1390478/000110465923027009/tm238142d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-027009

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer